Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Invesco Galaxy Bitcoin ETF (BTCO) vs Centene Corp (CNC) Price & Performance

Invesco Galaxy Bitcoin ETFTrade
Centene CorpTrade

Price performance (Past 24H)

Key statistics

Invesco Galaxy Bitcoin ETF vs Centene Corp — how do they compare? Invesco Galaxy Bitcoin ETF trades at $63.04, while Centene Corp trades at $66.33 (market cap $32.89B). The key difference: Centene Corp is trading nearer its 52-week high, Invesco Galaxy Bitcoin ETF nearer its low. Which is the better fit depends on your goals.

BTCOCNC
Sector
Crypto-linkedHealth
52-Week High
$125.14$68.72
52-Week Low
$58.40$26.17
Market Cap
$32.89B
Enterprise Value
$21.93B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invesco Galaxy Bitcoin ETF

BTCO stock trades at $64.60, up 0.86% today amid mixed technical signals. The overall technical picture shows bearish momentum with key support at $63 and resistance at $65. Financial ratios remain unavailable in current data, requiring fundamental verification through SEC filings.

Investment outlook hinges on forthcoming financial disclosures to assess valuation. Key risks include market volatility and competitive pressures. The stock's near-term direction will likely be driven by earnings results and institutional positioning updates.

Centene Corp

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Invesco Galaxy Bitcoin ETF

BTCO is a spot Bitcoin ETF that tracks the price of Bitcoin directly. It offers investors a regulated and convenient way to gain exposure to the digital currency through a traditional brokerage account without holding the asset.

Read more on BTCO

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC